ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,438, issued on April 29, was assigned to CUROCELL INC. (Daejeon, South Korea) and KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, South Korea).
"Enhanced immune cells using dual shRNA and composition including the same" was invented by Chan Hyuk Kim (Daejeon, South Korea), Young-Ho Lee (Daejeon, South Korea), Yujean Lee (Daejeon, South Korea), HyeongJi Lee (Daejeon, South Korea) and Sang Hoon Lee (Daejeon, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is broadly concerned with the field of cancer immunotherapy. For example, the present invention generally relates to an immune cell comprising a genetica...